A new study found that people with depression and anxiety who used GLP-1 drugs like Ozempic and Wegovy had a 42% lower risk ...

Researchers say lack of sleep could be a factor among young people interacting online for more than three hours a day ...

In a new GLP-1 study, semaglutide appeared to reduce the incidence of mental-health sick days and hospitalization, suggesting improved mood.

Inflammation markers may signal depression in women with type 2 diabetes, but vary based on depression symptoms and measures, according to a new study led by researchers at NYU Rory Meyers College of ...

Add Yahoo as a preferred source to see more of our stories on Google. Involving five million participants, the world’s largest and most diverse genetic study into depression revealed nearly 300 ...

A large multi-site naturalistic study evaluated an integrated behavioral health care model offering medication management, psychotherapy, and transcranial magnetic stimulation (TMS) at all Family Care ...

There is an urgent need for new and more effective treatments for depression. The results of a recent study show that psilocybin, an active compound found in certain mushrooms, can have a significant ...

Medicare Advantage (MA) beneficiaries who participated in a program using Vitalic showed significant improvement in depression and anxiety symptoms as well as lower rates of hospital admission and ...

Learn more about a clinical trial examining a potential new treatment for depression in adult patients. Managing symptoms of depression can feel overwhelming, but you are not alone. If you experience ...